RECRUTEMENTS

POST-DOC POSITION IN IMMUNO-VIROLOGY

We are currently inviting applications from enthusiastic post-doctoral candidates (2-year position) or PhD student (3-year position) to participate in our project supported by the French National Agency (ANR JCJC)
Plus de détails
Contact: Marlène Dreux
(05 Aout 2019)

 

ENGINEER POSITION IN VIROLOGY

 L’ingénieur(e) sera impliqué(e) sur un projet de thérapie génique au sein de l’équipe « Enveloped Viruses, Vectors & Immunotherapy » (EVIR)
La durée du contrat est de 1 an renouvelable
Plus de détails
Contact:
Els Verhoeyen
(18 juillet, 2019)


ENGINEER POSITION IN IMMUNO-VIROLOGY

Nous invitons l’application d’ingénieur(e) pour participer à notre projet soutenu par l’Agence Nationale Française.
Le programme de recherche est centré sur les virus et l’immunité innée, en particulier la réponse à l’interféron. CDD 6 mois
Plus de détails
Contact: Marlène Dreux
(11 mai, 2019)

Post-doc position in Immuno-Bacteriology.

Thomas Henry’s team is looking for a highly motivated applicant with a PhD in immunology and/or expertise in the field of primary human cells, inflammasome and/or innate immunity. Expertise in imaging would be also considered. The research project will focus on characterizing inflammasomes dysregulation in various autoinflammatory syndromes.  This position is opened starting in April 2019 with a one year contract renewable for up to 4 years.
More details
Contact: Thomas Henry

POST-DOCTORAL POSITION IN IMMUNO-VIROLOGY

A three year postdoctoral position is currently available in the group Immunovirology of Viral Infections, starting from May 2019, to study immunobiology of Nipah virus infection in its natural host and develop novel therapeutic anti-viral approaches.
More details
Contact : Branka Horvat

Post-doc position in virology

Host Pathogen Interaction in Lentiviral Infection Laboratory is actively seeking for one highly motivated post doctoral candidate to work on the relationship between human immunodeficiency viruses (HIVs) and the family of Interferon-Induced Transmembrane Proteins (IFITMs), exciting antiviral effectors capable of targeting HIV as well as a broad range of very distinct viruses. IFITMs block the fusion between viral and cellular membranes and the goal of the project is to determine the exact mechanism through which this is orchestrated.
More details
Contact: 
Dr. Andrea Cimarelli
(January 10th, 2019)

 

NOS TUTELLES ET PARTENAIRES